Vol 8, Supp. A (2017)
Case report
Published online: 2017-12-21
Efficacy and safety of long-term pomalidomide treatment in a patient with relapsed/refractory plasma cell myeloma — case report
Abstract
Pomalidomide is a new immunomodulatory drug used for treatment of relapsed/refractory plasma
cell myeloma (PCM). In this paper, we describe a case report of a patient with relapsed PCM was
subsequently treated with pomalidomide.
Keywords: relapsed/refractory plasma cell myelomaimmunomodulathory drugspomalidomidecontinuous treatment
